Meet the expert...
Karina Thorn, PHD
Corporate Vice President - RNA and Gene Therapies, Global Research Technologies at Novo Nordisk
Karina Thorn is currently the CVP and head of the newly established ‘RNA and Gene Therapies’ area at Novo Nordisk. She has a PhD in Biochemistry from the Faculty of Pharmaceutical Sciences, University of Copenhagen, Denmark. After working several years in Boston, US, Karina joined Novo Nordisk in 2014 as a Principal Scientist. During these seven years, she has successfully been driving research projects both as a project leader and as innovation focus group chair within rare disease research. Furthermore, Karina has served as department manager and been instrumental in establishing a broad palette of external Novo Nordisk partnerships as a result of her passion for unlocking therapeutic innovation via emerging technologies. Karina is a strong and innovative person who has committed her career to improving the lives of millions of people worldwide living with serious chronic conditions, which requires working with the highest professional standards, creativity and dedication.